Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| agilon health, inc.AGL · Entity 4698 | Director | June 02, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
agilon health, inc.
Report date June 02, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,765 |
Reported balance
After 2026-06-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 2,133 · Balance 16,765 F1: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. F3: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director
F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
F3: Includes restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 5, 2026 01:57 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 2,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041025 · wk-form4_1780624633.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,765 F1 · shares: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director F2 · balance_after: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. F3 · balance_after: Includes restricted stock units. Read SEC document |
| November 12, 2025 Filed Jan 31, 2026 00:30 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 81,000 | $0.63 | $50,940.90 |
DisclosureSEC source: 0001628280-26-004435 · wk-form4_1769819455.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,857 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.6251 to $0.6321, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 28, 2025 Filed May 30, 2025 22:32 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 78,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028718 · wk-form4_1748644349.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,857 F1 · shares: Restricted stock units that vest in full on May 28, 2026, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| December 05, 2024 Filed Dec 11, 2024 22:24 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 45,000 | $2.18 | $98,145.00 |
DisclosureSEC source: 0001628280-24-050831 · wk-form4_1733955878.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,133 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.165 to $2.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 29, 2024 Filed Jun 1, 2024 00:55 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 32,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026126 · wk-form4_1717203352.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,133 F1 · shares: Restricted stock units that vest in full on May 29, 2025, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:52 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024682 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,014 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:56 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 80,000 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001209191-23-019726 · doc4.xml · derivative · entry 3 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 80,000 shares Expires 2030-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on May 22, 2020, and vest on the first five anniversaries of the grant date, subject to continued service as a director. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:56 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 80,000 | $23.82 | $1,905,224.00 |
DisclosureSEC source: 0001209191-23-019726 · doc4.xml · nonDerivative · entry 2 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,392 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.68 to $23.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:56 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 80,000 | $4.50 | $360,000.00 |
DisclosureSEC source: 0001209191-23-019726 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 21:01 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025027 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,392 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 19,708 | $19.08 | $376,028.64 |
DisclosureSEC source: 0001209191-22-019283 · doc4.xml · nonDerivative · entry 2 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,456 F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 11,100 | $19.13 | $212,343.00 |
DisclosureSEC source: 0001209191-22-019283 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,164 F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:22 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 15,342 | $28.98 | $444,611.16 |
DisclosureSEC source: 0001209191-21-056208 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,264 F1 · balance_after: Includes restricted stock units. F2 · balance_after: On April 19, 2021, the reporting person received a distribution of 35,035 shares of the Issuer's common stock from COPC Practice Management, LLC, of which he continues to hold 19,708 shares after the transaction noted above. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 21:36 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 6,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027026 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,556 F1 · shares: Restricted stock units that vests in full on April 14, 2022, subject to continued service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.